Clarification regarding the transaction undertaken by Promoter Entity

www.capillarytech.com Date: August 25, 2026 To, To, BSE Limited National Stock Exchange of India Limited Listing Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex, Dalal Street, Mumbai – 400 001 Bandra (East), Mumbai – 400 051 Scrip Code: 544614 Symbol: CAPILLARY Dear Sir/Madam, Subject: Clarification regarding transaction undertaken by Promoter Entity Capillary Technologies India Limited (the "Company"), in relation to the intimation made on August 11, 2026 under Regulation 29 (2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and Regulation 7 (2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company wishes to provide the following clarification to its Stakeholders regarding the transaction undertaken by its Promoter, Capillary Technologies International Pte. Ltd. ("CTIPL"). The transaction involving approximately 4 (Four) % of the equity share capital of the Company, executed on August 10, 2026, was undertaken by CTIPL, the Singapore- based promoter entity of the Company, as part of a Secondary market transaction facilitating the exit of Peak XV Partners, an early-stage institutional private equity investor in CTIPL. It is important to clarify that the transaction should not be construed as an exit or divestment by the operational founders or as a reduction in their commitment or alignment with the Company. The transaction was undertaken in the context of the liquidity event of an institutional investor at the promoter entity level and forms part of the normal lifecycle of institutional private equity investments. Under the existing corporate structure, certain institutional investors hold their investment in the Company through CTIPL rather than directly in the Company. Accordingly, transactions undertaken pursuant to such investment and liquidity arrangements may be effected through CTIPL, being the promoter entity, and the corresponding regulatory disclosures are made in accordance with applicable requirements. The transaction therefore does not represent any change in the core promoter commitment towards the Company or its business, nor does it indicate any change in the operational founders’ continued involvement and alignment with the Company. Following the transaction, other institutional private equity investors continue to hold an aggregate equity holding of over 30 (Thirty) % in CTIPL. Any future liquidity events or structural exits undertaken by such investors may similarly be effected through CTIPL as part of the liquidity arrangement undertaken by such investors in respect of their investments, and reported in accordance with applicable regulatory requirements. The Company is making this clarification to ensure that shareholders and market participants have the appropriate context while evaluating the transaction and do not interpret the same as an exit or divestment by the operational founders or a change in the promoter group’s commitment towards the Company. Capillary Technologies India Limited CIN- L72200KA2012PLC063060 Regd. Office - 360, bearing PID No: 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru, Karnataka 560102 Email: secretarial@capillarytech.com Website: www.capillarytech.com Tel: 080-41225179 www.capillarytech.com This disclosure is being made for the information of all the Stakeholders of the Company. Thanking you, For Capillary Technologies India Limited Gireddy Bhargavi Reddy Company Secretary and Compliance Officer Membership No. A17091 Place: Bengaluru Capillary Technologies India Limited CIN- L72200KA2012PLC063060 Regd. Office - 360, bearing PID No: 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru, Karnataka 560102 Email: secretarial@capillarytech.com Website: www.capillarytech.com Tel: 080-41225179